All blog posts
Showing 240 out of 291 results
Challenges for the Consumer sector - Transformative Technology
Data Assets - Protecting and Driving Value in a Digital Age
Patent and Pharma Update - April 2019
Supreme Court upholds Court of Appeal's finding of obviousness in relation to a patented dosage regime
The Court of Justice of the European Union holds that Supplementary Protection Certificates cannot be obtained for new formulations of previously approved active ingredients in Abraxis (Case C-443/17)
Herbert Smith Freehills' Brexit Legal Guide updated - comparison of IP and pharma provisions in the draft Withdrawal Agreement versus the No Deal provisions promised by the UK Government
Preparations for the UPC continue despite an "unpredictable environment"
The UPC Preparatory Committee has issued a “Status of the Unified Patent Court Project” statement and review of 2018, confirming that there …
Advocate General proposes literal interpretation of Article 3(d) SPC Regulation in Abraxis (C-443/17)
The Advocate General of the CJEU proposed a narrow interpretation of Article 3(d) in the Opinion given yesterday in Abraxis …
Patent and Pharma Update - December 2018
Italy moves the unitary patent a step closer
CJEU rules on whether the NHS reimbursing off-label medicinal products for cost-cutting purposes conflicts with Directive 2001/83/EC
Novartis Farma S.p.A. v Italian Medicines Agency and Roche Italia S.p.A. On 21 November 2018, the CJEU issued an important decision in Novartis Farma v …
French court upholds validity of MSD's SPC protecting ezetimibe and simvastatin in combination
A French Court has upheld the validity of a Supplementary Protection Certificate ("SPC") protecting the ezetimibe+simvastatin combination under Article …
Showing 240 out of 291 results
View moreKey contacts
Rebekah Gay
Partner, Head of Intellectual Property, Sydney
Laura Orlando
Managing Partner, Milan Office, Milan
Sue Gilchrist
Consultant, Sydney
Peng Lei
Partner, Herbert Smith Freehills Kramer Kewei Joint Operation, Mainland China and Shanghai
Alexandra Neri
Partner, Paris
Dr Ina vom Feld
Partner, Germany
Sebastian Moore
Partner, Head Intellectual Property, London and Milan
Rachel Montagnon
Knowledge Counsel, London